Home/Filings/4/0001562180-18-002970
4//SEC Filing

Malone Daniel 4

Accession 0001562180-18-002970

CIK 0000105770other

Filed

Jun 11, 8:00 PM ET

Accepted

Jun 12, 6:00 PM ET

Size

8.6 KB

Accession

0001562180-18-002970

Insider Transaction Report

Form 4
Period: 2018-06-11
Malone Daniel
Vice President & Controller
Transactions
  • Exercise/Conversion

    Common Stock

    2018-06-11$16.05/sh+5,000$80,22534,020.393 total
  • Sale

    Common Stock

    2018-06-11$97.24/sh5,000$486,20029,020.393 total
  • Exercise/Conversion

    Stock Options (Right to Buy)

    2018-06-115,0000 total
    Exercise: $16.05Exp: 2019-02-24Common Stock (5,000 underlying)
Footnotes (2)
  • [F1]This transaction was executed in multiple trades at prices ranging from $97.11 USD to $97.28 USD; the price reported above reflects the weighted average sale price.
  • [F2]This award vests in 4 equal annual installments beginning on February 24, 2010.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001527326

Filing Metadata

Form type
4
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 6:00 PM ET
Size
8.6 KB